<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Blandino F</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Italian Ministry of Health</funding><pagination>6723-6737</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10359636</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>51(13)</volume><pubmed_abstract>The MUS81 complex is crucial for preserving genome stability through resolution of branched DNA intermediates in mitosis and also for the processing of deprotected replication forks in BRCA2-deficient cells. Because of the existence of two different MUS81 complexes in mammalian cells that act in M- or S-phase, whether and how the PARPi sensitivity of BRCA2-deficient cells is affected by loss of MUS81 function is unclear. Here, using a mutant of MUS81 that impairs its function in M-phase, we show that viability of BRCA2-deficient cells but not their PARPi sensitivity requires a fully-functional MUS81 complex in mitosis. In contrast, expression of a constitutively-active MUS81 is sufficient to confer PARPi resistance. From a mechanistic point of view, our data indicate that deregulated actio</pubmed_abstract><journal>Nucleic acids research</journal><pubmed_title>Phosphorylation status of MUS81 is a modifier of Olaparib sensitivity in BRCA2-deficient cells.</pubmed_title><pmcid>PMC10359636</pmcid><funding_grant_id>19971</funding_grant_id><funding_grant_id>RF-2016-02362022</funding_grant_id><funding_grant_id>21428</funding_grant_id><pubmed_authors>Noto A</pubmed_authors><pubmed_authors>Figlioli C</pubmed_authors><pubmed_authors>Pichierri P</pubmed_authors><pubmed_authors>Pugliese GM</pubmed_authors><pubmed_authors>Malacaria E</pubmed_authors><pubmed_authors>Franchitto A</pubmed_authors><pubmed_authors>Blandino F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phosphorylation status of MUS81 is a modifier of Olaparib sensitivity in BRCA2-deficient cells.</name><description>The MUS81 complex is crucial for preserving genome stability through resolution of branched DNA intermediates in mitosis and also for the processing of deprotected replication forks in BRCA2-deficient cells. Because of the existence of two different MUS81 complexes in mammalian cells that act in M- or S-phase, whether and how the PARPi sensitivity of BRCA2-deficient cells is affected by loss of MUS81 function is unclear. Here, using a mutant of MUS81 that impairs its function in M-phase, we show that viability of BRCA2-deficient cells but not their PARPi sensitivity requires a fully-functional MUS81 complex in mitosis. In contrast, expression of a constitutively-active MUS81 is sufficient to confer PARPi resistance. From a mechanistic point of view, our data indicate that deregulated actio</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2025-07-02T03:04:38.228Z</modification><creation>2025-07-02T03:04:38.228Z</creation></dates><accession>S-EPMC10359636</accession><cross_references><pubmed>37254810</pubmed><doi>10.1093/nar/gkad470</doi></cross_references></HashMap>